Immunovant Ownership 2024 | Who Owns Immunovant Now?
Institutional Ownership
5.80%
Insider Ownership
55.82%
Retail Ownership
38.38%
Institutional Holders
65.00
Immunovant Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 7.59% | 0.02% | 10,483,883 | 2,827,938 | 36.94% | 276,774,522 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.71% | 0.00% | 6,509,753 | 31,449 | 0.49% | 171,857,478 | Jun 30, 2024 |
| BLACKROCK INC. | 3.56% | 0.00% | 4,916,127 | 439,327 | 9.81% | 129,785,755 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 2.46% | 1.13% | 3,396,909 | 1,232,909 | 56.97% | 89,678,398 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 2.09% | 2.27% | 2,883,736 | 2,390,384 | 484.52% | 76,130,630 | Jun 30, 2024 |
| STATE STREET CORP | 1.97% | 0.00% | 2,718,956 | -922,951 | -25.34% | 71,780,438,000 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 1.68% | 0.24% | 2,320,902 | 511,730 | 28.29% | 61,271,813 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.39% | 1.21% | 1,923,786 | -1,039,426 | -35.08% | 50,787,950 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 1.38% | 8.76% | 1,907,704 | 25,000 | 1.33% | 50,363,386 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.32% | 0.46% | 1,823,415 | 533,911 | 41.40% | 48,138,156 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.18% | 0.03% | 1,625,220 | 1,625,220 | 100.00% | 42,906,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.02% | 0.00% | 1,414,002 | 97,175 | 7.38% | 37,336,725 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.99% | 1.38% | 1,362,827 | 563,773 | 70.56% | 35,978,633 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.99% | 0.00% | 1,361,649 | -500,394 | -26.87% | 35,948,000 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.86% | 0.94% | 1,185,654 | 35,531 | 3.09% | 31,301,266 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.85% | 0.04% | 1,174,816 | -90,482 | -7.15% | 31,015,142 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.83% | 0.01% | 1,144,849 | 40,571 | 3.67% | 30,224,013 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.80% | 0.01% | 1,101,868 | 232,652 | 26.77% | 29,089,315 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.73% | 7.85% | 1,011,879 | 384,651 | 61.33% | 26,713,606 | Jun 30, 2024 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 0.71% | 0.01% | 976,237 | - | - | 25,772,657 | Jun 30, 2024 |
Immunovant's largest institutional shareholder is FMR LLC, holding 7.59% of the company's total share outstanding, currently valued at $276.77M. The top 10 institutional shareholders own together 28.16% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPINE GLOBAL MANAGEMENT, LLC | 1.38% | 8.76% | 1,907,704 | 25,000 | 1.33% | 50,363,386 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.73% | 7.85% | 1,011,879 | 384,651 | 61.33% | 26,713,606 | Jun 30, 2024 |
| TYRO CAPITAL MANAGEMENT LLC | 0.18% | 3.00% | 250,620 | 152,953 | 156.61% | 6,616,368 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.50% | 2.99% | 695,428 | 182,535 | 35.59% | 18,359,299 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 0.50% | 2.97% | 692,406 | 151,111 | 27.92% | 18,279,518 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.24% | 2.56% | 325,000 | 130,000 | 66.67% | 8,580,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.35% | 2.38% | 476,543 | 415,780 | 684.27% | 12,580,735 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 2.09% | 2.27% | 2,883,736 | 2,390,384 | 484.52% | 76,130,630 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.19% | 2.15% | 260,000 | 135,000 | 108.00% | 6,864,000 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.99% | 1.38% | 1,362,827 | 563,773 | 70.56% | 35,978,633 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 0.54% | 1.35% | 750,990 | - | - | 19,826,136 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.20% | 1.27% | 276,925 | - | - | 7,310,821 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.42% | 1.23% | 575,000 | -1,200,000 | -67.61% | 15,180,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.39% | 1.21% | 1,923,786 | -1,039,426 | -35.08% | 50,787,950 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 0.52% | 1.15% | 720,177 | -249,444 | -25.73% | 19,012,673 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.60% | 1.15% | 825,000 | - | - | 21,780,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 2.46% | 1.13% | 3,396,909 | 1,232,909 | 56.97% | 89,678,398 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.25% | 1.05% | 346,088 | 61,088 | 21.43% | 9,136,723 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.66% | 1.02% | 908,000 | 403,000 | 79.80% | 23,971,200 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.07% | 0.96% | 91,500 | 6,200 | 7.27% | 2,416,000 | Jun 30, 2024 |
The largest Immunovant shareholder by % of total assets is ALPINE GLOBAL MANAGEMENT, LLC. The company owns 1.91M shares of Immunovant (IMVT), representing 8.76% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 7.59% | 0.02% | 10,483,883 | 2,827,938 | 36.94% | 276,774,522 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 2.09% | 2.27% | 2,883,736 | 2,390,384 | 484.52% | 76,130,630 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.18% | 0.03% | 1,625,220 | 1,625,220 | 100.00% | 42,906,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 2.46% | 1.13% | 3,396,909 | 1,232,909 | 56.97% | 89,678,398 | Jun 30, 2024 |
| NORGES BANK | 0.44% | 0.00% | 601,861 | 601,861 | 100.00% | 15,889,130 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.99% | 1.38% | 1,362,827 | 563,773 | 70.56% | 35,978,633 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.32% | 0.46% | 1,823,415 | 533,911 | 41.40% | 48,138,156 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 1.68% | 0.24% | 2,320,902 | 511,730 | 28.29% | 61,271,813 | Jun 30, 2024 |
| BLACKROCK INC. | 3.56% | 0.00% | 4,916,127 | 439,327 | 9.81% | 129,785,755 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.35% | 2.38% | 476,543 | 415,780 | 684.27% | 12,580,735 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.66% | 1.02% | 908,000 | 403,000 | 79.80% | 23,971,200 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.73% | 7.85% | 1,011,879 | 384,651 | 61.33% | 26,713,606 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.30% | 0.02% | 420,000 | 320,000 | 320.00% | 11,088,000 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.26% | 0.02% | 360,000 | 310,000 | 620.00% | 9,504,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.80% | 0.01% | 1,101,868 | 232,652 | 26.77% | 29,089,315 | Jun 30, 2024 |
| ABRDN PLC | 0.29% | 0.02% | 400,722 | 213,086 | 113.56% | 10,579,061 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.23% | 0.02% | 311,525 | 207,003 | 198.05% | 8,224,260 | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.14% | 0.01% | 199,800 | 199,800 | 100.00% | 5,274,720 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.50% | 2.99% | 695,428 | 182,535 | 35.59% | 18,359,299 | Jun 30, 2024 |
| TYRO CAPITAL MANAGEMENT LLC | 0.18% | 3.00% | 250,620 | 152,953 | 156.61% | 6,616,368 | Jun 30, 2024 |
As of Jun 30 2024, Immunovant's largest institutional buyer is FMR LLC. The company purchased 2.83M stocks of IMVT, valued at $276.77M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -1,383,810 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.42% | 1.23% | 575,000 | -1,200,000 | -67.61% | 15,180,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.39% | 1.21% | 1,923,786 | -1,039,426 | -35.08% | 50,787,950 | Jun 30, 2024 |
| STATE STREET CORP | 1.97% | 0.00% | 2,718,956 | -922,951 | -25.34% | 71,780,438,000 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 0.44% | 0.08% | 607,724 | -664,038 | -52.21% | 16,043,914 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | - | - | - | -629,882 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.99% | 0.00% | 1,361,649 | -500,394 | -26.87% | 35,948,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.03% | 0.00% | 36,929 | -370,725 | -90.94% | 974,925 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -273,289 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| REDMILE GROUP, LLC | 0.52% | 1.15% | 720,177 | -249,444 | -25.73% | 19,012,673 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -220,346 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.20% | 0.00% | 275,352 | -183,675 | -40.01% | 7,269,293 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.07% | 0.17% | 92,909 | -162,617 | -63.64% | 2,452,798 | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -160,000 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.10% | 0.01% | 140,698 | -148,687 | -51.38% | 3,714,427 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -137,682 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.59% | 0.00% | 817,038 | -120,923 | -12.89% | 21,569,803 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.05% | 0.03% | 65,100 | -114,900 | -63.83% | 1,718,640 | Jun 30, 2024 |
As of Jun 30 2024, Immunovant's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -1.38M shares of IMVT, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.18% | 0.03% | 1,625,220 | 1,625,220 | 100.00% | 42,906,000 | Jun 30, 2024 |
| NORGES BANK | 0.44% | 0.00% | 601,861 | 601,861 | 100.00% | 15,889,130 | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.14% | 0.01% | 199,800 | 199,800 | 100.00% | 5,274,720 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.02% | 113,931 | 113,931 | 100.00% | 3,007,778 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.04% | 0.04% | 58,624 | 58,624 | 100.00% | 1,547,674 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 0.04% | 0.53% | 55,210 | 55,210 | 100.00% | 1,457,544 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 32,956 | 32,956 | 100.00% | 867,920 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 31,228 | 31,228 | 100.00% | 824,419 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | 0.00% | 24,000 | 24,000 | 100.00% | 633,600 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.02% | 0.00% | 22,227 | 22,227 | 100.00% | 586,792 | Jun 30, 2024 |
| WINTON GROUP LTD | 0.01% | 0.04% | 20,675 | 20,675 | 100.00% | 545,820 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.01% | 0.01% | 17,684 | 17,684 | 100.00% | 466,858 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.01% | 0.07% | 13,323 | 13,323 | 100.00% | 351,727 | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | 0.01% | 0.07% | 12,634 | 12,634 | 100.00% | 333,538 | Jun 30, 2024 |
| HARBOUR CAPITAL ADVISORS, LLC | 0.01% | 0.06% | 9,400 | 9,400 | 100.00% | 258,594 | Jun 30, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.00% | 0.00% | 2,201 | 2,201 | 100.00% | 58,106 | Jun 30, 2024 |
| BFSG, LLC | 0.00% | 0.00% | 600 | 600 | 100.00% | 15,840 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | 0.00% | 0.00% | 155 | 155 | 100.00% | 5,008 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 113 | 113 | 100.00% | 2,938 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 59 | 59 | 100.00% | 1,558 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | - | - | 17 | 17 | 100.00% | 470 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | 7 | 7 | 100.00% | 196 | Jun 30, 2024 |
Immunovant's largest new institutional shareholder by number of shares is T. ROWE PRICE INVESTMENT MANAGEMENT, INC., purchased 1.63M shares, valued at $42.91M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -1,383,810 | -100.00% | - | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | - | - | - | -629,882 | -100.00% | - | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -273,289 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -220,346 | -100.00% | - | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -160,000 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -137,682 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -109,200 | -100.00% | - | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | - | - | - | -100,200 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -92,346 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -87,397 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -75,920 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -69,241 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -58,218 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -53,533 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -52,000 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -35,349 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -33,306 | -100.00% | - | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | - | - | - | -31,730 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -26,591 | -100.00% | - | Jun 30, 2024 |
| PEARL RIVER CAPITAL, LLC | - | - | - | -26,053 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -25,708 | -100.00% | - | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -21,397 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -20,690 | -100.00% | - | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -17,670 | -100.00% | - | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | - | - | - | -17,335 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -11,840 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -9,237 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -9,027 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -7,300 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -7,298 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -6,500 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -6,331 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -3,800 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,955 | -100.00% | - | Jun 30, 2024 |
| CREEKMUR ASSET MANAGEMENT LLC | - | - | - | -644 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
Immunovant's largest sold out institutional shareholder by shares sold is POINT72 ASSET MANAGEMENT, L.P., sold -1.38M shares, valued at -, as of undefined.
Immunovant Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Eaton Vance Enhanced Equity Income Fund II | 1.26% | 102,760 | - | - | Mar 31, 2024 |
| ALGER FUNDS II | 0.84% | 190,114 | 190,114 | - | Jan 31, 2024 |
| ALGER FUNDS | 0.81% | 779,496 | -197,159 | -20.19% | Jan 31, 2024 |
| Tax-Managed Multi-Cap Growth Portfolio | 0.74% | 19,759 | - | - | Jan 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.57% | 149,560 | 110,940 | 287.26% | Jan 31, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.52% | 486,055 | 175,115 | 56.32% | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.16% | 802,858 | 173,523 | 27.57% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.14% | 66,741 | -41,817 | -38.52% | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.14% | 120,895 | -98,253 | -44.83% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.13% | 3,770,260 | -164,250 | -4.17% | Feb 29, 2024 |
| ALGER PORTFOLIOS | 0.13% | 47,894 | - | - | Dec 31, 2023 |
| BlackRock Health Sciences Trust | 0.12% | 30,416 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.10% | 204,666 | - | - | Feb 29, 2024 |
| BlackRock Health Sciences Trust II | 0.10% | 256,486 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.09% | 103,100 | 103,100 | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 44,500 | - | - | Mar 31, 2024 |
| Tema ETF Trust | 0.08% | 3,432 | 3,432 | - | Feb 29, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.06% | 201,318 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.06% | 1,363 | - | - | Dec 31, 2023 |
| ALLSPRING VARIABLE TRUST | 0.03% | 21,000 | 7,500 | 55.56% | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 615,000 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 207,713 | 207,713 | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 12,100 | 60 | 0.50% | Mar 31, 2024 |
| EATON VANCE SPECIAL INVESTMENT TRUST | 0.02% | 38,669 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.02% | 1,790 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 95,224 | -3,021 | -3.07% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 127,953 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 5,741,815 | -277,915 | -4.62% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,978 | -219 | -2.67% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 32,011 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 822,543 | -59,300 | -6.72% | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 38,333 | 4,014 | 11.70% | Feb 29, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 780,367 | - | - | Mar 31, 2024 |
| EATON VANCE GROWTH TRUST | 0.01% | 103,205 | - | - | Feb 29, 2024 |
| IndexIQ ETF Trust | 0.01% | 20,982 | -1,428 | -6.37% | Jan 31, 2024 |
| ALPS ETF Trust | 0.01% | 92,302 | - | - | Feb 29, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 184,045 | 18,058 | 10.88% | Mar 31, 2024 |
| BARON SELECT FUNDS | 0.01% | 60,000 | 1,000 | 1.69% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,107 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 20,855 | 20,363 | 4138.82% | Dec 31, 2023 |
| UBS FUNDS | 0.00% | 18,351 | -295 | -1.58% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 115,210 | -7,630 | -6.21% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 151,259 | 2,016 | 1.35% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 33,015 | -4,473 | -11.93% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 232,210 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 580,924 | 19,784 | 3.53% | Feb 29, 2024 |
| NUVEEN INVESTMENT FUNDS INC | 0.00% | 92,235 | 46,753 | 102.79% | Jan 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 22,249 | - | - | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 4,878 | -4,000 | -45.06% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,585 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 2,246 | 2,214 | 6918.75% | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.00% | 19,614 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 219,949 | -13,114 | -5.63% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 1,927 | -2,720 | -58.53% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 41,002 | 1,388 | 3.50% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 6,890 | - | - | Mar 28, 2024 |
| ProFunds | 0.00% | 15,111 | 1,816 | 13.66% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 15,532 | -1,276 | -7.59% | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 34,580 | 11,214 | 47.99% | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.00% | 8,130 | -30,163 | -78.77% | Aug 31, 2023 |
| FINANCIAL INVESTORS TRUST | 0.00% | 91,651 | -213,571 | -69.97% | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 4,257 | - | - | Mar 31, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 41,023 | - | - | Mar 28, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 29,863 | 4,082 | 15.83% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 7,930 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,191 | -1,190 | -35.20% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 814,338 | -40,701 | -4.76% | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 3,600 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 16,596 | 256 | 1.57% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 172,011 | -27,539 | -13.80% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 8,474 | 267 | 3.25% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 600 | - | - | Jan 31, 2024 |
| PUTNAM FUNDS TRUST | 0.00% | 128,100 | - | - | Jan 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 18,146 | 6,246 | 52.49% | Mar 31, 2024 |
| Global X Funds | 0.00% | 24,787 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 17,725 | -3,847 | -17.83% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 288 | - | - | Apr 30, 2021 |
| Dimensional ETF Trust | 0.00% | 228,005 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,522 | -145 | -5.44% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 296,367 | 15,103 | 5.37% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 118,811 | -55,672 | -31.91% | Jan 31, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 20,000 | 4,921 | 32.63% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 24,314 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 10,279 | - | - | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 2,711 | -397 | -12.77% | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 46,491 | - | - | Mar 28, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,666 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 5,452 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 109,447 | 67,332 | 159.88% | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 6,555 | -75 | -1.13% | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 1,597 | 1,597 | - | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 32,076 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 20,941 | 15,989 | 322.88% | Feb 29, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 2,906 | 2,906 | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 18,900 | -500 | -2.58% | Mar 31, 2024 |
| SCHWAB INVESTMENTS | 0.00% | 15,864 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 286,475 | 56,933 | 24.80% | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 14,303 | -1,060 | -6.90% | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 6,157 | -65 | -1.04% | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 106 | - | - | Feb 29, 2024 |
Immunovant's largest mutual fund holder by % of total assets is "Eaton Vance Enhanced Equity Income Fund II", owning 102.76K shares, compromising 1.26% of its total assets.
Immunovant Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 65 | -72.34% |
| 31 Mar, 24 | 235 | -7.11% |
| 31 Dec, 23 | 253 | 18.22% |
| 30 Sep, 23 | 214 | 36.31% |
| 30 Jun, 23 | 157 | 3.97% |
| 31 Mar, 23 | 151 | 9.42% |
| 31 Dec, 22 | 138 | 20.00% |
| 30 Sep, 22 | 115 | 19.79% |
| 30 Jun, 22 | 96 | -19.33% |
| 31 Mar, 22 | 119 | -6.30% |
| 31 Dec, 21 | 127 | -4.51% |
| 30 Sep, 21 | 133 | - |
| 30 Jun, 21 | 133 | - |
| 31 Mar, 21 | 133 | -9.52% |
| 31 Dec, 20 | 147 | 26.72% |
| 30 Sep, 20 | 116 | 33.33% |
| 30 Jun, 20 | 87 | 112.20% |
| 31 Mar, 20 | 41 | 70.83% |
| 31 Dec, 19 | 24 | - |
As of 30 Jun 24, 65 institutions are holding Immunovant's shares, representing a decrease of -72.34% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 8,007,091 | -88.51% |
| 31 Mar, 24 | 69,688,195 | 1.94% |
| 31 Dec, 23 | 68,360,172 | 2.16% |
| 30 Sep, 23 | 66,916,900 | 20.66% |
| 30 Jun, 23 | 55,460,743 | -4.81% |
| 31 Mar, 23 | 58,264,185 | 3.08% |
| 31 Dec, 22 | 56,521,942 | 32.49% |
| 30 Sep, 22 | 42,659,730 | 6.30% |
| 30 Jun, 22 | 40,131,730 | 1.46% |
| 31 Mar, 22 | 39,554,126 | 4.49% |
| 31 Dec, 21 | 37,855,734 | 12.06% |
| 30 Sep, 21 | 33,781,209 | -12.38% |
| 30 Jun, 21 | 38,556,078 | -4.70% |
| 31 Mar, 21 | 40,455,735 | 0.29% |
| 31 Dec, 20 | 40,338,235 | 2.38% |
| 30 Sep, 20 | 39,400,232 | 37.93% |
| 30 Jun, 20 | 28,564,753 | 126.19% |
| 31 Mar, 20 | 12,628,676 | 8.50% |
| 31 Dec, 19 | 11,639,232 | - |
Immunovant (IMVT) has 8.01M shares outstanding as of 30 Jun 24, down -88.51% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 5.80% | 0.25% |
| 31 Mar, 24 | 48.22% | 2.16% |
| 31 Dec, 23 | 47.30% | 1.80% |
| 30 Sep, 23 | 51.28% | 2.53% |
| 30 Jun, 23 | 45.06% | 2.23% |
| 31 Mar, 23 | 44.95% | 2.33% |
| 31 Dec, 22 | 43.96% | 3.28% |
| 30 Sep, 22 | 36.59% | 3.09% |
| 30 Jun, 22 | 34.43% | 2.65% |
| 31 Mar, 22 | 36.06% | 3.33% |
| 31 Dec, 21 | 32.91% | 3.43% |
| 30 Sep, 21 | 30.97% | 2.00% |
| 30 Jun, 21 | 39.35% | 1.85% |
| 31 Mar, 21 | 46.10% | 2.72% |
| 31 Dec, 20 | 41.19% | 1.89% |
| 30 Sep, 20 | 46.71% | 2.87% |
| 30 Jun, 20 | 40.33% | 4.72% |
| 31 Mar, 20 | 29.23% | 3.63% |
| 31 Dec, 19 | 28.36% | - |
As of 30 Jun 24, Immunovant is held by 5.80% institutional shareholders, representing a 0.25% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 34 | -68.52% |
| 31 Mar, 24 | 108 | -20.00% |
| 31 Dec, 23 | 135 | 1.50% |
| 30 Sep, 23 | 133 | 49.44% |
| 30 Jun, 23 | 89 | 7.23% |
| 31 Mar, 23 | 83 | -9.78% |
| 31 Dec, 22 | 92 | 55.93% |
| 30 Sep, 22 | 59 | 34.09% |
| 30 Jun, 22 | 44 | -15.38% |
| 31 Mar, 22 | 52 | -14.75% |
| 31 Dec, 21 | 61 | -12.86% |
| 30 Sep, 21 | 70 | 2.94% |
| 30 Jun, 21 | 68 | -17.07% |
| 31 Mar, 21 | 82 | -16.33% |
| 31 Dec, 20 | 98 | 6.52% |
| 30 Sep, 20 | 92 | 21.05% |
| 30 Jun, 20 | 76 | 153.33% |
| 31 Mar, 20 | 30 | 25.00% |
| 31 Dec, 19 | 24 | - |
34 institutional shareholders have increased their position in IMVT stock as of 30 Jun 24 compared to 108 in the previous quarter (a -68.52% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -74.39% |
| 31 Mar, 24 | 82 | 3.80% |
| 31 Dec, 23 | 79 | 71.74% |
| 30 Sep, 23 | 46 | 4.55% |
| 30 Jun, 23 | 44 | 7.32% |
| 31 Mar, 23 | 41 | 41.38% |
| 31 Dec, 22 | 29 | -14.71% |
| 30 Sep, 22 | 34 | 21.43% |
| 30 Jun, 22 | 28 | -37.78% |
| 31 Mar, 22 | 45 | -2.17% |
| 31 Dec, 21 | 46 | 24.32% |
| 30 Sep, 21 | 37 | 2.78% |
| 30 Jun, 21 | 36 | 16.13% |
| 31 Mar, 21 | 31 | -20.51% |
| 31 Dec, 20 | 39 | 95.00% |
| 30 Sep, 20 | 20 | 81.82% |
| 30 Jun, 20 | 11 | 57.14% |
| 31 Mar, 20 | 7 | - |
| 31 Dec, 19 | - | - |
21 institutional shareholders have reduced their position in IMVT stock as of 30 Jun 24 compared to 82 in the previous quarter (a -74.39% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 65 | -72.34% | 8,007,091 | -88.51% | 5.80% | 0.25% | 34 | -68.52% | 21 | -74.39% |
| 31 Mar, 24 | 235 | -7.11% | 69,688,195 | 1.94% | 48.22% | 2.16% | 108 | -20.00% | 82 | 3.80% |
| 31 Dec, 23 | 253 | 18.22% | 68,360,172 | 2.16% | 47.30% | 1.80% | 135 | 1.50% | 79 | 71.74% |
| 30 Sep, 23 | 214 | 36.31% | 66,916,900 | 20.66% | 51.28% | 2.53% | 133 | 49.44% | 46 | 4.55% |
| 30 Jun, 23 | 157 | 3.97% | 55,460,743 | -4.81% | 45.06% | 2.23% | 89 | 7.23% | 44 | 7.32% |
| 31 Mar, 23 | 151 | 9.42% | 58,264,185 | 3.08% | 44.95% | 2.33% | 83 | -9.78% | 41 | 41.38% |
| 31 Dec, 22 | 138 | 20.00% | 56,521,942 | 32.49% | 43.96% | 3.28% | 92 | 55.93% | 29 | -14.71% |
| 30 Sep, 22 | 115 | 19.79% | 42,659,730 | 6.30% | 36.59% | 3.09% | 59 | 34.09% | 34 | 21.43% |
| 30 Jun, 22 | 96 | -19.33% | 40,131,730 | 1.46% | 34.43% | 2.65% | 44 | -15.38% | 28 | -37.78% |
| 31 Mar, 22 | 119 | -6.30% | 39,554,126 | 4.49% | 36.06% | 3.33% | 52 | -14.75% | 45 | -2.17% |
| 31 Dec, 21 | 127 | -4.51% | 37,855,734 | 12.06% | 32.91% | 3.43% | 61 | -12.86% | 46 | 24.32% |
| 30 Sep, 21 | 133 | - | 33,781,209 | -12.38% | 30.97% | 2.00% | 70 | 2.94% | 37 | 2.78% |
| 30 Jun, 21 | 133 | - | 38,556,078 | -4.70% | 39.35% | 1.85% | 68 | -17.07% | 36 | 16.13% |
| 31 Mar, 21 | 133 | -9.52% | 40,455,735 | 0.29% | 46.10% | 2.72% | 82 | -16.33% | 31 | -20.51% |
| 31 Dec, 20 | 147 | 26.72% | 40,338,235 | 2.38% | 41.19% | 1.89% | 98 | 6.52% | 39 | 95.00% |
| 30 Sep, 20 | 116 | 33.33% | 39,400,232 | 37.93% | 46.71% | 2.87% | 92 | 21.05% | 20 | 81.82% |
| 30 Jun, 20 | 87 | 112.20% | 28,564,753 | 126.19% | 40.33% | 4.72% | 76 | 153.33% | 11 | 57.14% |
| 31 Mar, 20 | 41 | 70.83% | 12,628,676 | 8.50% | 29.23% | 3.63% | 30 | 25.00% | 7 | - |
| 31 Dec, 19 | 24 | - | 11,639,232 | - | 28.36% | - | 24 | - | - | - |
Immunovant Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Immunovant's stock was made by Stout Jay S on Jul 26 2024, selling 2,813 shares at $27.76 per share (valued at $78.09K).
Immunovant Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 18 | - |
| Q2 2024 | 24 | 23 | 104.35% |
| Q1 2024 | - | 16 | - |
| Q4 2023 | 2 | 26 | 7.69% |
| Q3 2023 | - | 18 | - |
| Q2 2023 | 22 | 5 | 440.00% |
| Q1 2023 | - | 9 | - |
| Q4 2022 | 1 | 4 | 25.00% |
| Q3 2022 | 22 | 6 | 366.67% |
| Q2 2022 | - | 7 | - |
| Q1 2022 | 12 | 6 | 200.00% |
| Q4 2021 | 5 | - | - |
| Q3 2021 | 12 | 5 | 240.00% |
| Q2 2021 | 3 | - | - |
| Q1 2021 | 25 | - | - |
| Q3 2020 | 4 | - | - |
| Q2 2020 | 16 | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 42 | 2 | 2100.00% |
| Q2 2019 | 1 | 1 | 100.00% |
0 total buy trades, and 18 total sell trades (buy/sell ratio of 0.00%) were made by Immunovant's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 18 | - |
| Q2 2024 | - | 23 | - |
| Q1 2024 | - | 14 | - |
| Q4 2023 | 1 | 26 | 3.85% |
| Q3 2023 | - | 18 | - |
| Q2 2023 | - | 5 | - |
| Q1 2023 | - | 9 | - |
| Q4 2022 | 1 | 4 | 25.00% |
| Q3 2022 | 2 | 6 | 33.33% |
| Q2 2022 | - | 7 | - |
| Q1 2022 | - | 6 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 4 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q3 2020 | 2 | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 23 | - | - |
| Q2 2019 | 1 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 18 open market sell trades of Immunovant's stocks.
Immunovant Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ARQT | Arcutis Biotherapeutics, Inc. |
| LEGN | Legend Biotech Corporation |
| ACLX | Arcellx, Inc. |
| ABUS | Arbutus Biopharma Corporation |
| ETNB | 89bio, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
IMVT Ownership FAQ
Who Owns Immunovant?
Immunovant is owned by institutional shareholders (5.80%), insiders (55.82%), and public (38.38%). The largest institutional shareholder of Immunovant is FMR LLC (7.59% of total shares) and the top mutual fund owner is Eaton Vance Enhanced Equity Income Fund II (1.26% of total shares).
Who are the major institutional shareholders of Immunovant?
Immunovant's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, BLACKROCK INC., ARMISTICE CAPITAL, LLC, and DEEP TRACK CAPITAL, LP. The top five shareholders own together 20.41% of the company's share outstanding.
How many Immunovant shareholders are there?
As of Jun 2024, there are 65 institutional shareholders of Immunovant.
What percentage of Immunovant is owned by FMR LLC?
FMR LLC owns 10.48M shares of Immunovant, representing 7.59% of the company's total shares outstanding, valued at $276.77M (as of Jun 2024).
What percentage of Immunovant is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 6.51M shares of Immunovant (IMVT), compromising 4.71% of the company, valued at $171.86M.
What percentage of Immunovant is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Immunovant. The company owns 4.92M of the company's shares outstanding (worth $129.79M).